Wound News and Research

RSS

New algorithm guides plastic surgeons in managing women with ALCL after breast augmentation

In the wake of a recent FDA statement linking breast implants to a rare cancer called anaplastic large cell lymphoma, a newly updated algorithm provides plastic surgeons with guidance in managing women with breast lumps or swelling after breast augmentation.

15 Feb 2011

JDR releases research report on Osteonecrosis of the jaw

Osteonecrosis of the jaw is a debilitating bone condition that affects the jaws and occurs as a result of reduced local blood supply to the bone. The literature in this area has been severely limited since most investigations cannot evaluate sufficient numbers of afflicted individuals to accurately determine the incidence of the disease and associated risk factors.

14 Feb 2011

£160,000 award to devise anti-microbial collar to prevent bacterial infections associated with broken bones

Orthopaedic experts at The University of Nottingham are hoping to reduce the rate of infections that often occur in the pinning of broken bones by developing a special collar to counter dangerous microbes.

11 Feb 2011

Study finds breast cancer patients do not benefit from axillary lymph node dissection

Among patients with early-stage breast cancer that had spread to a nearby lymph node and who received treatment that included lumpectomy and radiation therapy, women who just had the sentinel lymph node removed did not have worse survival than women who had more extensive axillary lymph node dissection, according to a study in the February 9 issue of JAMA.

9 Feb 2011

LESSOnc technique promising new surgical option for certain liver cancers

Surgeons at UC San Diego Health System have identified a new application for "scarless" surgery tools that are normally used for natural orifice translumenal endoscopic surgery (NOTES).

9 Feb 2011

Researchers report promising new approach to treat diabetic wounds, bed sores

Loyola University Health System researchers are reporting on a promising new approach to treating diabetic wounds, bed sores, chronic ulcers and other slow-to-heal wounds.

8 Feb 2011

Rib-X commences Phase 2b trial to assess delafloxacin, linezolid, vancomycin for treatment of ABSSSI

Rib-X Pharmaceuticals, an antibiotics company with a broad development-stage pipeline, today announced the initiation of a Phase 2b clinical trial to evaluate delafloxacin, linezolid and vancomycin for the treatment of acute bacterial skin and skin structure infections, including infections caused by methicillin-resistant Staphylococcus aureus.

8 Feb 2011

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

A low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns, has been developed by a group of scientists from the Hebrew University of Jerusalem, Harvard Medical School and others in the U.S. and Japan.

8 Feb 2011

Misonix completes product registrations in major Latin American countries

Misonix, a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, announced the completion of product registrations in Argentina, Brazil, Colombia and Peru.

8 Feb 2011

Cleveland Clinic, JumpStart Ventures invest $500,000 in SironRX Therapeutics

JumpStart Ventures, the non-profit that invests in and partners with innovative, early-stage companies in Northeast Ohio, and Cleveland Clinic, announced a combined investment commitment of $500,000 in SironRX Therapeutics, Inc. The Cleveland-based company is developing a topical therapy to enhance healing of and decrease scar formation in wounds.

8 Feb 2011

Tufts announces public launch of Institute for Biomedical Partnerships, HUB website

Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.

8 Feb 2011

iFyber receives U.S. Army research Ffunding for wound healing technology

The United States Army Medical Research and Material Command, through the support of the Department of Defense Small Business Innovation Research Grant Program (SBIR), has awarded iFyber a Phase I grant. The award funds research related to controlled release of nitric oxide for wound healing.

7 Feb 2011

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

7 Feb 2011

SANUWAVE Health raises $4,102,660 from exercise of Options

SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, announces that it has raised gross proceeds of $4,102,660 from the exercise of Options that were issued as part of the sale of Units to accredited investors during 2010. The Options had an expiration date of January 31, 2011.

7 Feb 2011

iBridge Network announces tangible proof points for innovation, entrepreneurship

The recent launch of the 'Start-Up America Partnership', a coordinated public/private effort to celebrate, inspire and accelerate innovation and entrepreneurship and support the White House's Start-Up America initiative, validates the importance of stimulating economic growth, creating quality jobs, and building the new industries of the 21st Century.

5 Feb 2011

New data on CYTOMIMIC Technology's potential to stimulate tissue repair featured at 69th AAD

Johnson & Johnson Consumer Companies, Inc. today announced that its award-winning, breakthrough CYTOMIMIC™ Technology will be featured in a scientific poster at the 69th Annual Meeting of the American Academy of Dermatology (AAD), February 4-8, 2011, at the Ernest N. Morial Convention Center in New Orleans, LA.

5 Feb 2011

CVBT seeks FDA 'fast track' designation for CVBT-141B to treat ischemic diabetic wounds

CardioVascular BioTherapeutics, Inc. today announced it has submitted an application to the U.S. FDA to obtain "fast track" designation for CVBT-141B, its biological therapy to treat ischemic diabetic wounds based on the active ingredient fibroblast growth factor-1 (FGF-1).

4 Feb 2011

Positive results from Derma Sciences' Phase 2 trial with DSC127 in patients with diabetic foot ulcers

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced positive results from its Phase 2 clinical trial with DSC127 in patients with diabetic foot ulcers, including meeting the trial's primary endpoint, the proportion of study ulcers healed by 12 weeks as defined by 100% epithelialized with no drainage, as well as all secondary endpoints measured at this time.

3 Feb 2011

Scientia Advisors: Unmet need for new medical technologies to treat CVI and blood clots

In light of an aging population and increasing chronic vascular disease, there is a tremendous unmet need for new medical technologies to treat potentially dangerous chronic venous insufficiency (CVI) and blood clots, according to a Scientia Advisors review of the vascular device market released today. Both the CVI and the thrombosis segments present significant opportunities for medical device innovators.

3 Feb 2011

Baxter launches OLIMEL emulsion for parenteral nutrition

Baxter International today announced the launch of OLIMEL emulsion for infusion in Canada at the American Society of Parenteral and Enteral Nutrition's Clinical Nutrition Week.

From Baxter International Inc. 31 Jan 2011

Wound News and Research

New algorithm guides plastic surgeons in managing women with ALCL after breast augmentation

JDR releases research report on Osteonecrosis of the jaw

£160,000 award to devise anti-microbial collar to prevent bacterial infections associated with broken bones

Study finds breast cancer patients do not benefit from axillary lymph node dissection

LESSOnc technique promising new surgical option for certain liver cancers

Researchers report promising new approach to treat diabetic wounds, bed sores

Rib-X commences Phase 2b trial to assess delafloxacin, linezolid, vancomycin for treatment of ABSSSI

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

Misonix completes product registrations in major Latin American countries

Cleveland Clinic, JumpStart Ventures invest $500,000 in SironRX Therapeutics

Tufts announces public launch of Institute for Biomedical Partnerships, HUB website

iFyber receives U.S. Army research Ffunding for wound healing technology

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

SANUWAVE Health raises $4,102,660 from exercise of Options

iBridge Network announces tangible proof points for innovation, entrepreneurship

New data on CYTOMIMIC Technology's potential to stimulate tissue repair featured at 69th AAD

CVBT seeks FDA 'fast track' designation for CVBT-141B to treat ischemic diabetic wounds

Positive results from Derma Sciences' Phase 2 trial with DSC127 in patients with diabetic foot ulcers

Scientia Advisors: Unmet need for new medical technologies to treat CVI and blood clots

Baxter launches OLIMEL emulsion for parenteral nutrition

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News